Navigation Links
Clavis Pharma Raises NOK 129 Million (USD 20 Million) in a Private Placement to Fund Further Development of its Pipeline of Novel Anticancer Drug Candidates
Date:6/26/2009

parties.

    Clavis Pharma(TM) is a registered trademark of Clavis Pharma ASA.

    Contact:
    Geir Christian Melen
    Chief Executive Officer
    Office : +47-24-11-09-50
    Mobile : +47-91-30-29-65
    E-mail : geir.christian.melen@clavispharma.com

    Gunnar Manum
    Chief Financial Officer
    Office : +47-24-11-09-71
    Mobile : +47-95-17-91-90
    E-mail : gunnar.manum@clavispharma.com

    For international press enquiries:

    Mark Swallow / Nina Enegren / David Dible
    Citigate Dewe Rogerson
    Office : +44-207-282-2948
    E-mail : clavispharma@citigatedr.co.uk

'/>"/>
SOURCE Clavis Pharma ASA
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related biology technology :

1. Hearing Scheduled in the Delaware Court of Chancery for August 27, 2007 to Establish the Valid Approval and Consummation of the Merger Between PharmAthene, Inc. and Healthcare Acquisition Corp.
2. Pharmatek Adds Cytotoxic and High-Potent Drug Development Capabilities to San Diego Laboratory
3. Vion Pharmaceuticals Pays Interest on 7.75% Convertible Senior Notes
4. Skystar Bio-Pharmaceutical Announces Second Quarter 2007 Results
5. Proceedings to Affirm Merger Between PharmAthene and Healthcare Acquisition Corp Initiated in Delaware Chancery Court
6. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
7. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
8. XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007
9. Dragon Pharmaceutical Reports Growth in Sales and Profits during Second Quarter of 2007
10. Cadence Pharmaceuticals Reports Second Quarter 2007 Financial Results
11. Baxa Announces 2008 Dates for STAR Center Professional Pharmacy and Cleanroom Training

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2009)...mensional carbon layer in which the carbon atoms a...oneycomb. Carbon nanotubes are rolled-up sheets of... graphite. Graphene boasts some very special chara...ellent thermal conductor, and reconciles such conf... addition, graphene is impermeable to gases, which...
(Date:11/23/2009)...c’s Sporicidin disinfectant solution and wip...fectants against H1N1 and Influenza A., , ...24, 2009 -- Contec Inc, the leading manufacturer o... Sporicidin disinfectants have been deemed by the... including Pandemic 2009 H1N1 influenza A virus (t...
(Date:11/23/2009)...23/PRNewswire/--PearlTherapeuticsInc.,abiopharmace...eatmentofchronicrespiratorydiseases,todayannounced...ectors.Mr.Rosenhas25yearsofexperienceinthepharmace...atGileadSciencesandALZACorporation.Hisappointmenti..., "Howiebringsawealthofproductdevelopment,comme...
(Date:11/20/2009)...PRNewswire/ -- Veridiam (www.veridiam.com) won the... category at the 2009 Workplace Excellence Awards.... for Human Resources Management and recognize inno...,, Veridiam was one of nine winners, selected f...nored at the recent awards ceremony. San Diego-bas...
Breaking Biology Technology:Polymer with honeycomb structure 2Sporicidin Brand Disinfectant Kills H1N1 in 3 Minutes 2Pearl Therapeutics Appoints Howie Rosen to Board of Directors 2Veridiam Wins Workplace Excellence Crystal Award in Mid-Size Company Category 2
...NATICK, Mass. and MUNICH, Germany, Sept. 1 ,Boston...ced one-year data,from its landmark SYNTAX trial c...using the TAXUS(R) Express2(TM) Paclitaxel-Eluting...tery bypass graft (CABG) surgery. The,overall resu...erences,between PCI and CABG in rates of death or ...
...Four-month study detailing effects of treatment of...abs (ABL) ASAP 10 treatment indicates significant...r treatment; in-vitro laboratory work shows that ...irus into cells, "eventually destroying the virus"...rican Biotech Labs,developer of a new class of pro...
...GLENWOOD, Ill., Aug. 29 Landauer, Inc. (NYSE:,LDR...al radiation,monitoring, today announced the appoi...ts Board of Directors., Mr. Leatherman, currently...technology strategies and global contract negotiat...Chief Information Officer and,Executive Vice Presi...
Other Biology Technology:Landmark SYNTAX Trial Reports Comparable Safety Outcomes for Complex Patients Treated With TAXUS(R) Express2(TM) Stents or Bypass Surgery 2Landmark SYNTAX Trial Reports Comparable Safety Outcomes for Complex Patients Treated With TAXUS(R) Express2(TM) Stents or Bypass Surgery 3Landmark SYNTAX Trial Reports Comparable Safety Outcomes for Complex Patients Treated With TAXUS(R) Express2(TM) Stents or Bypass Surgery 4Landmark SYNTAX Trial Reports Comparable Safety Outcomes for Complex Patients Treated With TAXUS(R) Express2(TM) Stents or Bypass Surgery 5Preliminary Report of American Biotech Labs HIV Study Featured in Inaugural Issue of Journal of the Science of Healing Outcomes 2Landauer, Inc. Appoints Two New Members to Board of Directors 2
(Date:11/23/2009)... , , , , , , , ...Marshall, from the Environment Department at the U...yongia magomberae and his wider work in Tanzania....ion. , , , , , , , ... , , , A new species of chameleon has bee...
(Date:11/23/2009)...ix-week-old turkey poults could save millions of m...according to Dr. Gerald Steiner from the Dresden U...heir use of infrared spectroscopy to determine the... accurate method with the potential to be used by ...e eggs for breeding. The pilot study has just been...
(Date:11/23/2009)...l irritants such as air pollution and cigarette sm...oday in the American Journal of Respiratory and C...from Imperial College London and the University of...gs that can trigger coughing when a person is expo...st that their findings may ultimately lead to the ...
Breaking Biology News(10 mins):New chameleon species discovered in East Africa 2New chameleon species discovered in East Africa 3Rescuing male turkey chicks 2Research reveals exactly how coughing is triggered by environmental irritants 2Abbott and AstraZeneca Submit New Drug Application to the FDA for CERTRIAD 28TM 29 an Investigational Treatment for Mixed Dyslipidemia 47887 1Abbott and AstraZeneca Submit New Drug Application to the FDA for CERTRIAD 28TM 29 an Investigational Treatment for Mixed Dyslipidemia 47887 2Abbott and AstraZeneca Submit New Drug Application to the FDA for CERTRIAD 28TM 29 an Investigational Treatment for Mixed Dyslipidemia 47887 3Abbott and AstraZeneca Submit New Drug Application to the FDA for CERTRIAD 28TM 29 an Investigational Treatment for Mixed Dyslipidemia 47887 4Abbott and AstraZeneca Submit New Drug Application to the FDA for CERTRIAD 28TM 29 an Investigational Treatment for Mixed Dyslipidemia 47887 5Vision Pharma Is Granted Motion for Judgment 47885 1Vision Pharma Is Granted Motion for Judgment 47885 2Go Healthy Enters Letter of Intent to Acquire Premium Water Source 47883 1Go Healthy Enters Letter of Intent to Acquire Premium Water Source 47883 2
...ts need to be educated about managing fever in you...ly and often unnecessarily, according to a Queensl... QUT senior research fellow Anne Walsh conducted ...e childhood fever as part of her PhD. , Her resul...rics and Child Health. , Ms Walsh found that, of ...
.... 5 bioMETRX, Inc. (OTC,Bulletin Board: BMRX) a l...ts, today announced that it has acquired a patent ...o secure portable locks. The company believes tha...ket. For many years, consumers have been using por...s, to secure personal belongings in lockers,and st...
...e a unique way of feeding reminiscent of a science...scovered. After seizing prey in its jaws, a second... forward into the mouth, grabs the food and carrie...s is really an amazing innovation for feeding beha...stdoctoral researcher in the Section of Evolution ...
Other Biology News:Fever causing headaches for Aussie parents 2bioMETRX, Inc. Acquires Patent for Biometric Padlock 2'Alien' jaws help moray eels feed 2
Mouse Anti-Human RELT / TNFRSF19L Monoclonal Antibody, Unconjugated, Clone 238104 from R&D Systems
Nitric Oxide Synthase Radiometric Assay Kit from Cayman Chemical
Mouse Anti-Human Complement Component C5a Monoclonal Antibody, Unconjugated, Clone 295003 from R&D Systems
Mouse Anti-Human OSCAR Monoclonal Antibody, Unconjugated, Clone 259501 from R&D Systems
Biology Products: